EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Subsequent pregnancy outcomes among women with tubal ectopic pregnancy treated with methotrexate

Scott C Mackenzie iD, Catherine A Moakes iD, W Colin Duncan iD, Stephen Tong iD, Andrew W Horne iD

Reproduction and Fertility · 2023

DOI: 10.1530/raf-23-0019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproduction and Fertility, 2023. Verfasst von Scott C Mackenzie und 4 weiteren Autor:innen. Beteiligte Einrichtung: MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Pregnancy, Tubal, Pregnancy, Ectopic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graphical abstract Lay summary An ectopic pregnancy occurs when an embryo implants outside of the uterus, usually in a fallopian tube. When detected early, treatment is often with a medication called methotrexate. When methotrexate does not work, surgery is required. A recent clinical trial of ectopic pregnancy treatment (called GEM3) found that adding a drug called gefitinib to methotrexate did not reduce the need for surgery. We have used data from the GEM3 trial, combined with data collected 12 months after the trial finished, to investigate post-methotrexate pregnancy outcomes. We found no difference in pregnancy rates, pregnancy loss rates and recurrent ectopic pregnancy rates between those treated medically only and those who subsequently also needed surgery. The surgical technique used also did not affect pregnancy rates. This research provides reassurance that women with ectopic pregnancies treated medically who need surgery have similar post-treatment pregnancy outcomes to those treated successfully medically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy, TubalPregnancy, EctopicPregnancyAnimalsFemaleMethotrexatePregnancy OutcomeFallopian TubesHumans

Stichwörter der Autor:innen

methotrexatepregnancy outcomesrecurrencerisk factortubal ectopic pregnancy

Substanzen

Methotrexate

Autor:innen und Institutionen

  • MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.
  • Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia.

ORCID-Profile: Scott C Mackenzie, Catherine A Moakes, W Colin Duncan, Stephen Tong, Andrew W Horne

Förderung

  • Medical Research Council

Zitieren

APA

Mackenzie, S. C., Moakes, C. A., Duncan, W. C., Tong, S., & Horne, A. W. (2023). Subsequent pregnancy outcomes among women with tubal ectopic pregnancy treated with methotrexate. Reproduction and Fertility. https://doi.org/10.1530/raf-23-0019

Vancouver

Mackenzie SC, Moakes CA, Duncan WC, Tong S, Horne AW. Subsequent pregnancy outcomes among women with tubal ectopic pregnancy treated with methotrexate. Reproduction and Fertility. 2023. doi:10.1530/raf-23-0019

BibTeX
@article{Mackenzie2023,
  author = {Mackenzie, Scott C and Moakes, Catherine A and Duncan, W Colin and Tong, Stephen and Horne, Andrew W},
  title = {Subsequent pregnancy outcomes among women with tubal ectopic pregnancy treated with methotrexate},
  journal = {Reproduction and Fertility},
  year = {2023},
  doi = {10.1530/raf-23-0019}
}
Kostenlos starten →